APA (7th ed.) Citation

MC, T., FC, B., R, B., L, T., P, M., NC, N., . . . R, C. B. (2026). Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early triple-negative breast cancer: A multicenter real-world cohort. NPJ breast cancer. https://doi.org/10.1038/s41523-026-00966-5

Chicago Style (17th ed.) Citation

MC, Tavares, et al. "Neoadjuvant Pembrolizumab Plus Chemotherapy in Germline BRCA-mutated Early Triple-negative Breast Cancer: A Multicenter Real-world Cohort." NPJ Breast Cancer 2026. https://doi.org/10.1038/s41523-026-00966-5.

MLA (9th ed.) Citation

MC, Tavares, et al. "Neoadjuvant Pembrolizumab Plus Chemotherapy in Germline BRCA-mutated Early Triple-negative Breast Cancer: A Multicenter Real-world Cohort." NPJ Breast Cancer, 2026, https://doi.org/10.1038/s41523-026-00966-5.